Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tresa McGranahan

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|April 10, 2017
A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung CancerTresa McGranahan, Seema Nagpal
Therapeutic Advances in Medical Oncology|May 23, 2017
History and current state of immunotherapy in glioma and brain metastasisTresa McGranahan, Gordon Li, Seema Nagpal
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Quantitative analysis of signaling mechanisms controlling adult neural progenitor cell proliferationDavid V Schaffer, Analeah O'Neill, Lisa Hochrein, et al.
Current Treatment Options in Oncology|February 22, 2019
Current State of Immunotherapy for Treatment of GlioblastomaTresa McGranahan, Kate Elizabeth Therkelsen, Sarah Ahmad, et al.
Neurology|June 13, 2025
Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant RadiotherapyTyler Lanman, Isabella Densmore, Seema Nagpal, et al.
The Neurohospitalist|January 24, 2019
Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case ReportAmy Li, Tresa McGranahan, Elaine Su, et al.
Clinical Lung Cancer|May 24, 2022
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal DiseaseCristina M Merkhofer, Boryana Eastman, Isabella Densmore, et al.
Journal of Neuro-Oncology|January 3, 2025
Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: updateNataniel Mandelberg, Tiffany R Hodges, Tony J C Wang, et al.
Journal of Neuro-Oncology|January 5, 2021
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphomaAlipi V Bonm, Alec W Gibson, Leona A Holmberg, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 25, 2024
Environmental Enrichment and Health Outcomes Among Low-Grade Glioma Brain Tumor SurvivorsKarl Cristie F Figuracion, Christine Mac Donald, David Hunt, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|April 10, 2017
A Neuro-oncologist's Perspective on Management of Brain Metastases in Patients with EGFR Mutant Non-small Cell Lung CancerTresa McGranahan, Seema Nagpal
Therapeutic Advances in Medical Oncology|May 23, 2017
History and current state of immunotherapy in glioma and brain metastasisTresa McGranahan, Gordon Li, Seema Nagpal
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Quantitative analysis of signaling mechanisms controlling adult neural progenitor cell proliferationDavid V Schaffer, Analeah O'Neill, Lisa Hochrein, et al.
Current Treatment Options in Oncology|February 22, 2019
Current State of Immunotherapy for Treatment of GlioblastomaTresa McGranahan, Kate Elizabeth Therkelsen, Sarah Ahmad, et al.
Neurology|June 13, 2025
Characteristics and Outcomes of Patients With IDH-Mutant Grade 2 and 3 Gliomas After Deferred or Adjuvant RadiotherapyTyler Lanman, Isabella Densmore, Seema Nagpal, et al.
The Neurohospitalist|January 24, 2019
Coexistence of Neuromyelitis Optica and Amyotrophic Lateral Sclerosis: A Case ReportAmy Li, Tresa McGranahan, Elaine Su, et al.
Clinical Lung Cancer|May 24, 2022
Systemic Treatment Patterns and Outcomes in Patients With EGFR Mutated Non-small Cell Lung Cancer and Leptomeningeal DiseaseCristina M Merkhofer, Boryana Eastman, Isabella Densmore, et al.
Journal of Neuro-Oncology|January 3, 2025
Congress of Neurological Surgeons systematic review and evidence based guideline on neuropathology for WHO grade II diffuse glioma: updateNataniel Mandelberg, Tiffany R Hodges, Tony J C Wang, et al.
Journal of Neuro-Oncology|January 5, 2021
A single-center retrospective analysis of outcome measures and consolidation strategies for relapsed and refractory primary CNS lymphomaAlipi V Bonm, Alec W Gibson, Leona A Holmberg, et al.
The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses|October 25, 2024
Environmental Enrichment and Health Outcomes Among Low-Grade Glioma Brain Tumor SurvivorsKarl Cristie F Figuracion, Christine Mac Donald, David Hunt, et al.
Pageof 2